Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA weight loss injectable pen is a pre-filled, once-weekly subcutaneous injection — either tirzepatide (Mounjaro) or semaglutide (Wegovy) — that works through gut-hormone receptors to reduce appetite and slow gastric emptying. Both are licensed in the UK for adults and are only available following a clinical assessment by a prescriber. Many people find that knowing exactly what to expect from the pen itself makes starting far less daunting than they imagined. This page covers the practical reality: how the device works, what the first few weeks feel like, and how to use it safely at home.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The word "pen" describes the format: a compact, pre-filled auto-injector that looks a little like a fat highlighter. You press it against the skin, press a button, and the injection happens automatically. There is no exposed needle to handle, no glass vial, no measuring. This is a deliberate design choice. Eli Lilly's Mounjaro KwikPen and Novo Nordisk's Wegovy pen both shield the needle before and after use, which removes most of the anxiety that comes with the word "injection".
Each pen contains enough tirzepatide or semaglutide for four weekly doses, and the strength is set at the factory. You cannot accidentally dial the wrong amount. If you want to understand the broader landscape of injectable weight loss drugs available in the UK, that page walks through the mechanism differences between the two medicines.
The practical habit that takes under a minute: before you inject, run your finger around the cap of the pen and check the expiry printed on the label. Pens stored correctly in the fridge (2–8°C) are fine up to that date; one glance before each dose is enough. For exact room-temperature storage windows, the Patient Information Leaflet inside the box is the authority, those windows differ slightly between products and strengths, so follow the leaflet rather than any number you read online.
The three licensed injection sites are the abdomen (at least a couple of inches from the navel), the front of the thigh, and the back of the upper arm. Rotating around these areas each week is not just a preference, it gives skin and underlying tissue time to recover, which keeps absorption consistent and reduces the risk of a lump or hardened patch developing where you repeatedly inject.
Most people describe the sensation as a brief pinch or sting that lasts a second or two. The device's shielded needle is fine-gauge and short. Injecting into skin that is slightly pinched upward and letting the alcohol from any site preparation dry fully first both help. You can find alcohol swabs designed for this purpose at our pharmacy if you need them.
Redness, mild bruising or a small itchy weal at the injection site can happen and usually clears within a day or two. If you notice a persistent hard nodule or skin changes that don't resolve, mention it to your prescriber at the next review. The NHS medicines page for tirzepatide lists injection-site reactions among the known side effects and notes when to seek further advice.
The starting dose exists to let your digestive system adjust, not to produce dramatic weight loss from week one. Nausea is the most commonly reported side effect early on, and it tends to peak in the day or two after an injection before settling. Loose stools, belching and a general feeling of fullness can accompany it. For most people, these effects are noticeable but manageable, and they ease as the body adapts.
Eating smaller portions, staying well hydrated, and avoiding very fatty or spicy meals in the day after your injection are the practical steps our prescribers most often suggest during the early weeks. The weight loss injectables overview covers the clinical evidence behind these medicines in more detail if you want the broader picture alongside the day-to-day experience.
One thing worth knowing: the appetite shift usually becomes noticeable before significant weight change does. People often report feeling full after much smaller meals within the first couple of weeks. The weight follows over months, not days. Clinical trials measured outcomes at 68–72 weeks for a reason. If you are weighing up your options, our page on choosing a weight loss injectable can help you compare what is available before you commit to a course of treatment. The STEP 1 trial published in the New England Journal of Medicine reported an average 15% body weight reduction for semaglutide over 68 weeks; tirzepatide data from SURMOUNT-1 showed averages around 20–21% at 72 weeks. Those numbers come from thousands of adults following a full treatment course alongside lifestyle changes, not from week two.
Used pens contain a retracted but used needle. They must not go into household recycling or the general bin. A sharps disposal container is the correct way to store them until your local council or pharmacy take-back scheme collects them. Many GP surgeries and high-street pharmacies accept small sharps bins; your local council website will list the nearest drop-off point.
Some people ask whether they need replacement needles. The Mounjaro KwikPen and Wegovy pen are single-use per weekly injection; you use one pen per dose and then dispose of the whole device. Replacement needles are relevant only for certain reusable pen formats, which are not the standard dispensing format for these medicines in the UK. If you are ever unsure what has been dispensed, check with your prescriber before injecting. You can also read a summary of the different weight loss injection pen formats on this site.
If you are considering starting treatment, the first step is a clinical consultation. A prescriber reviews your medical history, current medicines, weight and health conditions before deciding whether and at what dose a weight loss injectable pen is appropriate for you. Our guide to injectable drugs for weight loss sets out how the main medicines compare, which can be useful reading before your consultation. Alongside that, you may also find it helpful to read about how a weight loss injection works in practice so you know what to expect from your first dose onwards. To see how that process works at nume, or to speak to our prescribers, the consultation is free and takes place the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.